Wealth Enhancement Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.65M	Buy	+76,278	New	+$4.61M	0.01%	854
2026 Q1	–	Sell	-21,552	Closed	-$771K	–	3636
2025 Q4	$771K	Buy	21,552 +803	+4%	+$63.1K	﹤0.01%	2134
2025 Q3	$1.87M	Buy	20,749 +7,102	+52%	+$514K	﹤0.01%	1479
2025 Q2	$986K	Buy	13,647 +5,693	+72%	+$413K	﹤0.01%	1765
2025 Q1	$909K	Buy	7,954 +230	+3%	+$14K	﹤0.01%	1648
2024 Q4	$389K	Buy	7,724 +2,578	+50%	+$135K	﹤0.01%	2175
2024 Q3	$238K	Buy	+5,146	New	+$183K	﹤0.01%	2336

Other funds holding CORT

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return

Evanson Financial Mclean, Virginia $2.04B AUM

Wealth Enhancement Advisory Services's CORT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 76,278 shares worth $6.65M. The stake represents 0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in CORT as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in CORT in Q3 2024 and has held it in 7 quarters since. 54 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Wealth Enhancement Advisory Services held 76,278 shares of Corcept Therapeutics worth $6.65M as of Q2 2026.
Corcept Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
Corcept Therapeutics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #854 holding.
Wealth Enhancement Advisory Services first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 7 quarters since.
54 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.